Article

Schwind installs 1,000th laser

Schwind eye-tech-solutions GmbH this month is celebrating the 1,000th installation of its proprietary laser system for refractive surgery (Schwind Aramis 750S).

Kleinostheim, Germany-Schwind eye-tech-solutions GmbH this month is celebrating the 1,000th installation of its proprietary laser system for refractive surgery (Schwind Amaris 750S).

“In reaching the number 1,000, we have achieved yet another milestone in the history of our company. This is a great motivation for us to continue to expand our strong market position,” said Rolf Schwind, the company’s chief executive officer.

The first Schwind laser was delivered to South Korea in 1992. Today, laser systems from Schwind have been installed worldwide, with the exception of the United States.

According to estimates by market research company Market Scope, approximately 4,000 excimer lasers from various manufacturers are in operation for the correction of visual defects in Asia, Australia, Europe, and Central and Latin America. Excluding the U.S. market, Schwind achieved a 34% global market share in laser sales in 2011, according to Market Scope.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.